GDC-0927
- Generic Name
- GDC-0927
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H28FNO4
- CAS Number
- 2100830-77-9
- Unique Ingredient Identifier
- ST9B0EMC0H
- Background
GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
- First Posted Date
- 2014-12-15
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT02316509
- Locations
- 🇺🇸
Massachusetts General Hospital., Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇪🇸Hospital General Universitario Gregorio Maranon, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath